|
|
|
|
| LEADER |
03091cam a2200385 a 4500 |
| 001 |
c000396621 |
| 003 |
CARM |
| 005 |
20140314124916.0 |
| 008 |
140314s1994 nyua b 001 0 eng d |
| 010 |
|
|
|a 93021010
|
| 019 |
1 |
|
|a 69841445
|5 LACONCORD2021
|
| 020 |
|
|
|a 0879935642 (acid-free)
|
| 035 |
|
|
|a (OCoLC)28802064
|5 LACONCORD2021
|
| 040 |
|
|
|a DNLM/DLC
|b eng
|c DLC
|d DLC
|d TOC
|
| 050 |
1 |
0 |
|a RC268.4
|b .M63 1994
|
| 060 |
0 |
0 |
|a QZ 267 M71846 1993
|
| 082 |
0 |
4 |
|a 616.99406
|2 20
|
| 245 |
0 |
0 |
|a Molecular and immunologic approaches /
|c edited by Brian E. Huber, Brian I. Carr.
|
| 260 |
|
|
|a Mount Kisco, N.Y. :
|b Futura Pub. Co.,
|c c1994.
|
| 300 |
|
|
|a xii, 307 p. :
|b ill. ;
|c 24 cm.
|
| 490 |
1 |
|
|a Cancer therapy in the twenty-first century ;
|v vol. 1
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
|
|a Introduction / Brian E. Huber -- Sect. I. Oncogenes and Tumor-Suppressor Genes. Ch. 1. Oncogenes and Tumor-Suppressor Genes: Potential in Cancer Therapy / J. A. Boyd. Ch. 2. Oncogenes: Therapeutic Implications / G. J. Tricot, R. A. Hromas, T. B. Leemhuis, E. Srour and R. Hoffman. Ch. 3. Potential of Tyrosine Kinase Receptors as Therapeutic Targets In Cancer / M. J. Page, M. Crompton, K. Affleck and P. Spence -- Sect. II. Advances in Cancer Prediction, Diagnosis, and Prognosis. Ch. 4. Advances in Tumor Markers / T. I. Khansur. Ch. 5. The Polymerase Chain Reaction: Its Role in the Future of Molecular and Diagnostic Oncology / E. S. Kawasaki -- Sect. III. Antisense-Oligonucleotide and Triple-Helix Therapy. Ch. 6. Towards a New Chemotherapy: Oligodeoxynucleotide Analogues as Informational Drugs / J. S. Cohen. Ch. 7. Potential Therapeutic Usefulness of Intermolecular Triplex DNA / J. E. Gee, S. Ebbinghaus, C. Mayfield, G. Sanders, K. Shrestha, B. Rodu, K. Rabenau and D. M. Miller.
|
| 505 |
0 |
|
|a Sect. IV. Immunology. Ch. 8. Advances in Monoclonal Antibody-Guided Radioimmunotherapy and the Diagnosis of Cancer / J. Schlom, D. E. Milenic, K. Siler, T. Yokota, S. V. S. Kashmir and P. Horan-Hand. Ch. 9. Bispecific Antibodies as Cancer Therapeutics / M. W. Fanger and P. M. Morganelli. Ch. 10. Chimeras, Castor Beans, and Cancer: Antibody and Ligand-Toxin Conjugates as Therapeutic Agents / T. W. Griffin, L. Recht, E. Maher, H. Delichatsios and V. Raso. Ch. 11. Multiple Roles for Cytokines in the Development of Monoclonal Antibody-Based Approaches to Tumor Detection and Therapy / J. W. Greiner, F. Guadagni, C. D. Ullmann, C. A. Nieroda, E. C. Borden and J. Schlom.
|
| 650 |
|
0 |
|a Cancer
|x Genetic aspects.
|
| 650 |
|
0 |
|a Cancer
|x Molecular aspects.
|
| 650 |
|
0 |
|a Cancer
|x Immunological aspects.
|
| 700 |
1 |
|
|a Huber, Brian Edward.
|
| 700 |
1 |
|
|a Carr, Brian I.
|
| 852 |
8 |
|
|b CARM
|p 0601409
|f BK
|
| 852 |
8 |
|
|b SCAN
|h A3:AE35B0
|i B12264
|p 0601409
|f BK
|
| 830 |
|
0 |
|a Cancer therapy in the twenty-first century ;
|v vol. 1
|
| 999 |
f |
f |
|i 7859de84-9b87-566e-a207-7d8a466c32ca
|s 24db9c76-9f12-55d7-8a3b-d3d7d0ae0b09
|
| 952 |
f |
f |
|p Can circulate
|a CAVAL
|b CAVAL
|c CAVAL
|d CARM 1 Store
|i book
|m 0601409
|
| 952 |
f |
f |
|a CAVAL
|b CAVAL
|c CAVAL
|d Unmapped Location
|e B12264
|f A3:AE35B0
|h Other scheme
|